Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Johnson and Johnson
McKesson
Healthtrust
Harvard Business School
Mallinckrodt
McKinsey
QuintilesIMS

Generated: May 25, 2018

DrugPatentWatch Database Preview

WESTCORT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Westcort patents expire, and what generic alternatives are available?

Westcort is a drug marketed by Sun Pharm Inds Inc and is included in two NDAs.

The generic ingredient in WESTCORT is hydrocortisone valerate. There are sixty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.
Summary for WESTCORT
Drug patent expirations by year for WESTCORT
Synonyms for WESTCORT
(14R)-17-HYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL PENTANOATE
(1S,10S,11S,15S,17S,2R,14R)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl pentanoate
[(17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
[11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
11|A,17,21-Trihydroxypregn-4-ene-3,20-dione 17-valerate
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-valerate
11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl pentanoate
17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadec-6-en-14-yl pentanoate
57524-89-7
68717P8FUZ
AC-13156
AC1L27Q7
AC1NQMC9
AC1NR05S
AKOS015917554
AKOS015961188
BC205714
BRD-A23290232-001-01-5
C26H38O6
CAS-57524-89-7
CHEBI:50865
CHEBI:94344
CHEMBL1200562
CHEMBL67128
Cortisol 17-valerate
CPD000058860
CPD001496932
CTK6D5448
D02288
DSSTox_CID_25633
DSSTox_GSID_45633
DSSTox_RID_81015
DTXSID9045633
EINECS 260-786-8
EN300-51036
FZCHYNWYXKICIO-FZNHGJLXSA-N
HMS2235G11
HMS3259K22
Hydrocortisone 17-valerate
Hydrocortisone 17-valerate, analytical standard
hydrocortisone pentanoate
HYDROCORTISONE VALERATE
Hydrocortisone valerate (USP)
Hydrocortisone valerate [USAN:USP]
Hydrocortisone valerate [USAN]
Hydrocortisone valerate, United States Pharmacopeia (USP) Reference Standard
Hydrocortisone-17-valerate
I14-9728
LS-175850
MCULE-3492234187
MLS000028655
MLS001076102
NC00604
NCGC00018263-02
NCGC00024016-03
Opera_ID_1123
PL001479
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-((1-oxopentyl)oxy)-, (11beta)-
Pregn-4-ene-3,20-dione,11,21-dihydroxy-17-[(1-oxopentyl)oxy]-, (11b)-
SAM002548926
SAM002589925
SCHEMBL80603
SMR000058860
ST075195
Tox21_110853
Tox21_110853_1
UNII-68717P8FUZ
Westcort (TN)
Z1894
ZINC4213520

US Patents and Regulatory Information for WESTCORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc WESTCORT hydrocortisone valerate CREAM;TOPICAL 017950-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc WESTCORT hydrocortisone valerate OINTMENT;TOPICAL 018726-001 Aug 8, 1983 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
UBS
Chubb
Express Scripts
AstraZeneca
Deloitte
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.